Stocks · Health care · Pharmaceutical Preparations

Xencor Inc

XNCR Clue Score24

United States Fiscal year ends December CIK 0001326732 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

21 insiders · 189 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

John S Stafford III

10% owner

$12.49M (31)

$69.14M (23)

−$56.65M

11,061,556

14.88%

$144.46M

−11.0%

John R Desjarlais

Sr. Vice President & CSO

—

$9.60M (21) scheduled

−$9.60M

263,831

0.3548%

$3.45M

+712.9%

Bassil I Dahiyat

President & CEO

—

$8.49M (18) scheduled

−$8.49M

546,316

0.7348%

$7.13M

+340.1%

Edgardo Baracchini Jr

Chief Business Officer

—

$4.98M (12) scheduled

−$4.98M

207

0.0003%

$2.70K

0.0%

John J Kuch

Sr. Vice President & CFO

—

$4.14M (12) scheduled

−$4.14M

121,070

0.1628%

$1.58M

+95.1%

Paul A Foster

Chief Medical Officer

—

$3.87M (7) scheduled

−$3.87M

4,952

0.0067%

$64.67K

0.0%

Ronin Capital, LLC entity

10% owner

—

$2.27M (2)

−$2.27M

5,012,430

6.74%

$65.46M

−1.5%

Bruce L A Carter

Director

—

$739.50K (5)

−$739.50K

48,578

0.0653%

$634.43K

+636.0%

Allen Yang

Sr. Vice President & CMO

—

$595.95K (6)

−$595.95K

73,364

0.0987%

$958.13K

+4,597%

Alan Bruce Montgomery

Director

—

$519.01K (5) scheduled

−$519.01K

25,849

0.0348%

$337.59K

—

Kurt A Gustafson

Director

—

$471.20K (4) scheduled

−$471.20K

25,011

0.0336%

$326.64K

—

Celia Eckert

SVP, General Counsel

—

$431.22K (12)

−$431.22K

76,918

0.1034%

$1.00M

+1,205%

Nancy Valente

EVP, Chief Development Officer

—

$197.66K (3)

−$197.66K

49,169

0.0661%

$642.15K

+2,171%

Kevin Charles Gorman

Director

$1.01K (1)

$176.80K (3) scheduled

−$175.78K

21,680

0.0292%

$283.14K

—

Ellen Feigal

Director

—

$168.73K (3) scheduled

−$168.73K

12,340

0.0166%

$161.16K

—

Richard J Ranieri

Director

—

$146.74K (3) scheduled

−$146.74K

24,011

0.0323%

$313.58K

—

Bart Jan Cornelissen

Sr. Vice President & CFO

—

$101.53K (3)

−$101.53K

75,898

0.1021%

$991.23K

+3,710%

Dagmar Rosa-Bjorkeson

Director

—

$51.76K (1)

−$51.76K

8,490

0.0114%

$110.88K

—

Barbara Klencke

Director

—

—

—

29,974

0.0403%

$391.46K

—

Todd E Simpson

Director

—

—

—

23,988

0.0323%

$313.28K

—

Raymond Joseph Deshaies

Director

—

—

—

10,302

0.0139%

$134.54K

—